Use Case B: Exploring
delays in breast cancer treatment during the COVID pandemic
2022-06-24
Use Case B on delayes in breast cancer treatment during the COVID
pandemic
Health Systems across Europe had to reorganise healthcare services
reallocating resources towards providing complex assistance to COVID-19
patients. COVID-19 surge of cases during the different epidemic waves
requiring intensive care has lead countries to cancel or postpone
non-urgent care (i.e. elective surgery). This use case will seek to
elicit whether there has been an increase in time to treatment in women
diagnosed with breast cancer in the month previous to the lockdown
measures, as compared with the woman diagnosed with breast cancer before
that period and whether the distribution of this delay could be
influenced by the healthcare reorganisation measures due to the COVID
pandemic.
LOCAL ANALYSES
This analyses corresponds with the local part of the analysis
(country-specific). Please, provide feedback on your outputs, both data
quality analysis (EDA), HTML report and aggregated output to the Use
Case B leaders to complete the overall analyses.
Use Case B: Exploring delays in breast cancer treatment during the COVID pandemic
Warning: No information available on ‘socecon_lvl_cd’
Exploratory Analysis (BE)
Distribution of times from diagnosis to treatment for breast cancer patients
Warning: No information available on ‘time_dx_to_immunotherapy_nm’
Warning: No information available on ‘time_dx_to_immunotherapy_nm’
Use Case B: Exploring delays in breast cancer treatment during the COVID pandemic
Warning: No information available on ‘socecon_lvl_cd’
Exploratory Analysis (ITA)
Distribution of times from diagnosis to treatment for breast cancer patients
Use Case B: Exploring delays in breast cancer treatment during the COVID pandemic
Exploratory Analysis (GBR)
Distribution of times from diagnosis to treatment for breast cancer
patients
Use Case B: Exploring delays in breast cancer treatment during the COVID pandemic
Exploratory Analysis (ESP)
Distribution of times from diagnosis to treatment for breast cancer
patients